Kenneth Inchausti
Corporate Officer/Principal at Novo Nordisk, Inc.
Kenneth Inchausti active positions
| Companies | Position | Start | End |
|---|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 2014-09-24 | - |
| Public Communications Contact | - | 2014-09-24 |
Career history of Kenneth Inchausti
Former positions of Kenneth Inchausti
| Companies | Position | Start | End |
|---|---|---|---|
| OCUGEN, INC. | Investor Relations Contact | 2021-06-20 | 2022-05-31 |
| Public Communications Contact | 2021-06-20 | 2022-05-31 |
Training of Kenneth Inchausti
| Old Dominion University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Stock Market
- Insiders
- Kenneth Inchausti
- Experience
